Sign in Pull a receipt

IVVD

Invivyd, Inc.

Healthcare · Biotechnology

$57.04 sample

+0.33 (+0.58%) 1D

Market cap

$55.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-14

Alerts

8

Price$57.04 +16.36% 3M daily closessample

57.0447.57

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: EVP, Operations
Oct 21INSInsider sell: EVP, Operations
Oct 14SEC8-K filed: material event
Oct 08INSInsider sell: Chief Financial Officer
Oct 01INSInsider sell: Director
Sep 28INSInsider buy: Chief Executive Officer
Sep 17INSInsider buy: General Counsel
Sep 11INSInsider buy: Director

Sign up to see the real IVVD record →

Company facts

SEC EDGAR registration

Name: Invivyd, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -45sample, -100 to +100
Reporting currency: USD

Who is positioning in IVVD

sample

Insiders: 24 insider transactions over 90 days, net selling, $612.6M
Congress: 5 members traded over 90 days
Institutions · 13F: 44 funds hold $1.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.1B +19.1% y/y

Q4 2024Q3 2026

Inventory$1.2B +11.4% y/y

Q4 2024Q3 2026

Accounts receivable$967.4M +16.9% y/y

Q4 2024Q3 2026

Total debt$2.6B +19.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $18.5B +3.2% 3M
Sample peer B: $18.9B -4.8% 3M
Sample peer C: $16.1B +4.6% 3M
Sample peer D: $52.3B +14.4% 3M
Sample peer E: $54.0B +12.9% 3M